Jemincare 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CMAB007 (omalizumab biosimilar) / Mabpharm Limited
NCT06365879: To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria

Recruiting
3
392
RoW
CMAB007, Omalizumab alpha, Xolair, Omalizumab
Taizhou Mabtech Pharmaceutical Co.,Ltd
Chronic Spontaneous Urticaria
11/25
05/26
NCT05897008: The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity

Completed
1
114
RoW
CMAB007, Xolair
Taizhou Mabtech Pharmaceutical Co.,Ltd
Healthy Volunteers
06/22
09/22
JMB2002 / Jemincare
ChiCTR2100042150: Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic profile and immunogenicity of JMB-2002 injection in Chinese healthy subjects after intravenous infusion of single dose

Not yet recruiting
1
40
 
5mg/Kg dose of JMB2002 single intravenous infusion ;15mg/Kg dose of JMB2002 single intravenous infusion ;30mg/Kg dose of JMB2002 single intravenous infusion ;50mg/Kg dose of JMB2002 single intravenous infusion
Shu Lan (Hang Zhou) Hospital; Jiangsu Jiyu Biopharmaceutical Co., Ltd, self-financing
Novel Coronavirus Pneumonia (COVID-19)
 
 
JYB1904 / RAPT Therap
NCT06438757: Trial of JYB1904 in Patients With Allergic Asthma

Recruiting
2
60
RoW
JYB1904, Omalizumab
Jemincare
Allergic Asthma
10/25
10/25
NCT06509334: Trial of JYB1904 in Chronic Spontaneous Urticaria.

Recruiting
2
135
RoW
JYB1904, Omalizumab
Jemincare
Chronic Spontaneous Urticaria
07/26
07/26
NCT05449535: Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects

Completed
1
56
RoW
JYB1904, Omalizumab, Xolair, JYB1904 Placebo
Jemincare
Healthy
01/23
01/23
HBI-2438 / HUYA Bioscience
ChiCTR2200059986: An Open-label, Multicenter Phase I/II Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Anti-tumor Activity of JMKX001899 Tablets in Patients with Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation (Phase Ia) and Patients with Non-small Cell Lung Cancer (Phase Ib, II)

Not yet recruiting
1/2
175
 
JMKX001899monotherapy
Fudan University Shanghai Cancer Center; Fudan University Shanghai Cancer Center, Shanghai Jemincare Pharmaceuticals Co., Ltd.
Non-small cell lung cancer
 
 
NCT06348290: Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

Not yet recruiting
1
72
NA
JMKX001899, Itraconazole, Midazolam, Rifampin, dextromethorphan, Rosuvastatin, digoxin
Jemincare
Solid Tumor, Adult
05/24
09/24
NCT06473948: To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

Not yet recruiting
1
27
NA
JMKX001899, Placebo
Jemincare
Solid Tumor, Adult
09/24
02/25
NCT05485974: A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

Recruiting
1
44
US
HBI-2438
HUYABIO International, LLC.
Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer, Cancer of Pancreas, Colon Cancer, Solid Tumor, Cancer
08/25
08/25
JMKX002992 / Roche
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CMAB007 (omalizumab biosimilar) / Mabpharm Limited
NCT06365879: To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria

Recruiting
3
392
RoW
CMAB007, Omalizumab alpha, Xolair, Omalizumab
Taizhou Mabtech Pharmaceutical Co.,Ltd
Chronic Spontaneous Urticaria
11/25
05/26
NCT05897008: The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity

Completed
1
114
RoW
CMAB007, Xolair
Taizhou Mabtech Pharmaceutical Co.,Ltd
Healthy Volunteers
06/22
09/22
JMB2002 / Jemincare
ChiCTR2100042150: Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic profile and immunogenicity of JMB-2002 injection in Chinese healthy subjects after intravenous infusion of single dose

Not yet recruiting
1
40
 
5mg/Kg dose of JMB2002 single intravenous infusion ;15mg/Kg dose of JMB2002 single intravenous infusion ;30mg/Kg dose of JMB2002 single intravenous infusion ;50mg/Kg dose of JMB2002 single intravenous infusion
Shu Lan (Hang Zhou) Hospital; Jiangsu Jiyu Biopharmaceutical Co., Ltd, self-financing
Novel Coronavirus Pneumonia (COVID-19)
 
 
JYB1904 / RAPT Therap
NCT06438757: Trial of JYB1904 in Patients With Allergic Asthma

Recruiting
2
60
RoW
JYB1904, Omalizumab
Jemincare
Allergic Asthma
10/25
10/25
NCT06509334: Trial of JYB1904 in Chronic Spontaneous Urticaria.

Recruiting
2
135
RoW
JYB1904, Omalizumab
Jemincare
Chronic Spontaneous Urticaria
07/26
07/26
NCT05449535: Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects

Completed
1
56
RoW
JYB1904, Omalizumab, Xolair, JYB1904 Placebo
Jemincare
Healthy
01/23
01/23
HBI-2438 / HUYA Bioscience
ChiCTR2200059986: An Open-label, Multicenter Phase I/II Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Anti-tumor Activity of JMKX001899 Tablets in Patients with Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation (Phase Ia) and Patients with Non-small Cell Lung Cancer (Phase Ib, II)

Not yet recruiting
1/2
175
 
JMKX001899monotherapy
Fudan University Shanghai Cancer Center; Fudan University Shanghai Cancer Center, Shanghai Jemincare Pharmaceuticals Co., Ltd.
Non-small cell lung cancer
 
 
NCT06348290: Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

Not yet recruiting
1
72
NA
JMKX001899, Itraconazole, Midazolam, Rifampin, dextromethorphan, Rosuvastatin, digoxin
Jemincare
Solid Tumor, Adult
05/24
09/24
NCT06473948: To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

Not yet recruiting
1
27
NA
JMKX001899, Placebo
Jemincare
Solid Tumor, Adult
09/24
02/25
NCT05485974: A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

Recruiting
1
44
US
HBI-2438
HUYABIO International, LLC.
Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer, Cancer of Pancreas, Colon Cancer, Solid Tumor, Cancer
08/25
08/25
JMKX002992 / Roche
No trials found

Download Options